Natural antibodies and complement modulate intimal thickening after arterial injury

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 5, 2009, Pages

  Dimayuga, Paul C ^a   Cesena, Fernando H Y ^a   Chyu, Kuang Yuh ^a   Yano, Juliana ^a   Amorn, Allen ^a   Fishbein, Michael C ^b   Shah, Prediman K ^a   Cercek, Bojan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Complement system; Immune system

Indexed keywords

ANTIBODY; COBROTOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RAG1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CONTROLLED STUDY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CAROTID ARTERY INJURIES; COMPLEMENT C3; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, KNOCKOUT; SPLEEN; TUNICA INTIMA;

EID: 70449659422     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00114.2009     Document Type: Article

References (19)

1. Avrameas S. Natural autoantibodies: from "horror autotoxicus" to "gnothi seauton". Immunol Today 12: 154-159, 1991.
2. Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, Cercek B. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 85: 1192-1198, 1999. (Pubitemid 30430625)
3. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 7: 812-818, 1995.
4. Cowell RM, Plane JM, Silverstein FS. Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci 23: 9459-9468, 2003. (Pubitemid 37323048)
5. Dimayuga P, Cercek B, Oguchi S, Fredrikson GN, Yano J, Shah PK, Jovinge S, Nilsson J. Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol 22: 644-649, 2002. (Pubitemid 34408747)
6. Dimayuga PC, Li H, Chyu KY, Fredrikson GN, Nilsson J, Fishbein MC, Shah PK, Cercek B. T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol 25: 2528-2534, 2005. (Pubitemid 43732274)
7. Faria-Neto JR, Chyu KY, Li X, Dimayuga PC, Ferreira C, Yano J, Cercek B, Shah PK. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 189: 83-90, 2006. (Pubitemid 44468069)
8. Fleming SD, Tsokos GC. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5: 89-92, 2006. (Pubitemid 43136464)
9. Gearhart PJ, Johnson ND, Douglas R, Hood L. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts. Nature 291: 29-34, 1981. (Pubitemid 11125250)
10. Keren G, Keren P, Barshack I, Pri-Chen S, George J. The effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury. Atherosclerosis 159: 77-83, 2001. (Pubitemid 33016624)
11. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. I-PLA2 activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196: 655-665, 2002. (Pubitemid 35024443)
12. Lutz HU, Stammler P, Bianchi V, Trueb RM, Hunziker T, Burger R, Jelezarova E, Spath PJ. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 103: 465-472, 2004. (Pubitemid 38140074)
13. Lutz HU, Stammler P, Jelezarova E, Nater M, Spath PJ. High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 88: 184-193, 1996. (Pubitemid 26230686)
14. Manderson AP, Pickering MC, Botto M, Walport MJ, Parish CR. Continual low-level activation of the classical complement pathway. J Exp Med 194: 747-756, 2001. (Pubitemid 32983011)
15. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877, 1992.
16. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102: 910-918, 1998. (Pubitemid 28419236)
17. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93: 942-951, 1999. (Pubitemid 29067860)
18. Shagdarsuren E, Bidzhekov K, Djalali-Talab Y, Liehn EA, Hristov M, Matthijsen RA, Buurman WA, Zernecke A, Weber C. C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 117: 70-78, 2008. (Pubitemid 350291183)
19. Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183: 2343-2348, 1996. (Pubitemid 26158925)